قالب وردپرس درنا توس
Home / Business / Why Novavax stock crashed today

Why Novavax stock crashed today



what happened

Vaccine expert Novax (Nasdaq stock code: NVAX) The stock sell-off on Monday could not be stopped. Although the company reported seemingly good news, investors fled the stock, causing the stock price to fall by nearly 10% that day.

So

The good news is that Novavax is launching a Phase 3 clinical trial of NVX-CoV2373, which has entered the coronavirus race. The company plans to recruit 30,000 participants to participate in the PREVENT-19 study, which will be conducted in approximately 115 locations in the United States and Mexico.

Like other coronavirus vaccine developers, Novavax is supported by the US government’s “Warp Speed ​​Operation”

;. A department of the Ministry of Health and Human Services, the Department of Advanced Biomedical Research and Development (BARDA), will provide PREVENT-19 with up to $1.6 billion.

Masked medical researchers in gloves use microscopes at work.

Image source: Getty Images.

In addition to early clinical trials in South Africa, the United States and Australia, the biotech company is also conducting a Phase 3 study of NVX-CoV2373 in the United Kingdom.

Earlier this month, two coronavirus vaccines have received emergency use authorization from the US Food and Drug Administration. They are all, modernMRNA-1273 and Pfizer/Biological TechnologyThe BNT162b2 has been managed nationwide.

How to do

Since NVX-CoV2373 has just entered the third phase of large-scale testing, Novavax is far behind Moderna, Pfizer and BioNTech. Even with a certain degree of subsidy, the leader of this game will still get a lot of benefits from mass vaccination; for some investors, Novavax may be considered too backward.




Source link